Berman Robert

The estimated Net Worth of Berman Robert is at least $111 Million dollars dollars as of 10/23/2021. Berman Robert is the Special Projects & Med Ovrsght of Biohaven Pharmaceutical Holding Co Ltd. Berman Robert owns over 790,891 shares of Biohaven Pharmaceutical Holding Co Ltd stock worth over $111 Million dollars .

Berman Robert mailing address: C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510

Insider Roles

Name Transaction Date Position
Biohaven Pharmaceutical Holding Co Ltd 2020-07-08 officer: Special Projects & Med Ovrsght
EMBED
SAVE

Berman Robert trading performance

Average Relative Return

50.13%

Average relative return per transaction

Outperforming Transactions

100%

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .

Berman Robert trading performance analysis

1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 7.09 9.74 32.02 50.13 219.75 151.64
Relative Return to S&P 500(%) 4.55 7.44 22.73 41.63 200.03 129.48

Berman Robert trading transactions

Ticker Company Price Insider Name Insider Position Date Buy/Sell Insider Trading Shares Shares Change Price Cost(000) Final Share Price Change Since Insider Trade (%) Dividend Yield % PE Ratio Market Cap ($M)
NVNO
enVVeno Medical Corp
$9.90
BERMAN ROBERT ANDREW
CEO
2021-05-18 Buy
3,000
407.61%
$5.47
$16.41
3,736
80.99%
0
At Loss
93.72
REKR
Rekor Systems Inc
$12.37
BERMAN ROBERT ALAN
CEO, 10% Owner
2020-08-05 Buy
2,725,836
81.15%
$2.57
$7,005.40
6,084,940
381.32%
0
At Loss
542.30
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Special Projects & Med Ovrsght
2020-07-08 Sell
58,404
-6.88%
$75.25
$4,394.90
790,891
85.91%
0
At Loss
9,149.63
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Special Projects & Med Ovrsght
2020-06-23 Sell
4,296
-0.54%
$75.05
$322.42
790,891
86.41%
0
At Loss
9,149.63
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Special Projects & Med Ovrsght
2020-06-19 Sell
62,300
-7.30%
$75.27
$4,689.32
790,891
85.86%
0
At Loss
9,149.63
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Special Projects & Med Ovrsght
2019-12-30 Sell
125,000
-13.65%
$53.22
$6,652.50
790,891
162.87%
0
At Loss
9,149.63
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Chief Medical Officer
2019-06-27 Buy
2,500
0.32%
$42.30
$105.75
790,550
230.73%
0
At Loss
9,149.63
NVNO
enVVeno Medical Corp
$9.90
BERMAN ROBERT ANDREW
CEO
2019-03-12 Buy
21,740
100%
$1.15
$25.00
869.60
760.87%
0
At Loss
93.72
NVNO
enVVeno Medical Corp
$9.90
BERMAN ROBERT ANDREW
CEO
2019-03-12 Buy
18,382
100%
$1.36
$25.00
735.28
627.94%
0
At Loss
93.72
REKR
Rekor Systems Inc
$12.37
BERMAN ROBERT ALAN
CEO, 10% Owner
2018-11-16 Buy
22,000
18.14%
$0.85
$18.70
143,247
1,355.29%
0
At Loss
542.30
REKR
Rekor Systems Inc
$12.37
BERMAN ROBERT ALAN
CEO, 10% Owner
2018-11-16 Buy
22,000
18.14%
$0.85
$18.70
143,247
1,355.29%
0
At Loss
542.30
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Chief Medical Officer
2018-06-12 Sell
76,692
-23.91%
$36.36
$2,788.52
244,000
284.76%
0
At Loss
9,149.63
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Chief Medical Officer
2018-06-12 Sell
104,155
-11.72%
$36.33
$3,783.95
784,601
285.08%
0
At Loss
9,149.63
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Chief Medical Officer
2018-06-07 Sell
25,845
-2.80%
$36.01
$930.68
898,205
288.50%
0
At Loss
9,149.63
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Chief Medical Officer
2018-05-10 Sell
35,000
-3.65%
$26.82
$938.70
924,050
421.63%
0
At Loss
9,149.63
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Chief Medical Officer
2018-04-10 Sell
35,000
-3.52%
$24.66
$863.10
959,050
467.32%
0
At Loss
9,149.63
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Chief Medical Officer
2018-03-12 Sell
35,000
-3.40%
$30.11
$1,053.85
994,050
364.63%
0
At Loss
9,149.63
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Chief Medical Officer
2018-02-12 Sell
35,000
-3.29%
$30.42
$1,064.70
1,029,050
359.89%
0
At Loss
9,149.63
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Chief Medical Officer
2018-01-10 Sell
35,000
-3.17%
$27.52
$963.20
1,070,050
408.36%
0
At Loss
9,149.63
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Chief Medical Officer
2017-12-19 Sell
10,000
-0.90%
$24.10
$241
1,105,050
480.50%
0
At Loss
9,149.63
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Chief Medical Officer
2017-12-11 Sell
25,000
-2.19%
$21.28
$532
1,115,050
557.42%
0
At Loss
9,149.63
BHVN
Biohaven Pharmaceutical Holding Co Ltd
$139.90
Berman Robert
Chief Medical Officer
2017-11-14 Sell
160,000
-12.31%
$25.76
$4,121.60
1,140,050
443.09%
0
At Loss
9,149.63
ACTG
Acacia Research Corp
$5.53
BERMAN ROBERT ANDREW
COO, Gen. Counsel, Sec.
2006-05-02 Sell
27,500
-100%
$11.50
$316.25
0
-51.91%
0
At Loss
274.33
ACTG
Acacia Research Corp
$5.53
BERMAN ROBERT ANDREW
COO, Gen. Counsel, Sec.
2006-04-27 Sell
82,500
-100%
$11
$907.50
0
-49.73%
0
At Loss
274.33
Total 24
  • 1

Berman Robert personal network

Name Position Linked company